| Literature DB >> 22605803 |
Shuichi Yano1, Kanako Kobayashi, Toshikazu Ikeda.
Abstract
Isoniazid (H) or rifampicin (R) mono-resistant disease can be treated easily and effectively with first-line drugs, while combined H and R resistance (ie, multidrug-resistant tuberculosis (MDRTB)) requires treatment with at least four agents, including a quinolone and an injectable agent. Drug-resistant Mycobacterium tuberculosis strains are reported to be extremely difficult to cultivate invitro. The authors report a case of MDRTB that required 2 years for diagnosis, and was detected only in sputum culture on solid medium. Physicians should consider MDRTB if TB is suspected but pathogens are not detected.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22605803 PMCID: PMC3316804 DOI: 10.1136/bcr.02.2010.2775
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X